Owasp Top10 in Pharmaceuticals | Compliance

AI Security and Compliance in Pharmaceuticals

Trustwise delivers an AI Security and Control Layer, which includes AI Trust Management for Agentic AI Systems. Modern AI projects fail to scale, not because of a lack of ambition, but due to unreliability, inefficiency, and lack of control. This is the Trust Gap, a critical barrier to achieving widespread AI adoption. The emergence of agentic AI only widens this gap, introducing greater complexity and risk. Our solutions (Harmony Ai) minimize the Trust Gap throughout the entire AI lifecycle, from simulation and verification to optimization and governance. Trustwise helps large organizations realize AI Trust and Security at scale.

Minimizing the Trust Gap

We embed real-time security, control, and alignment into every agent so innovation scales without compromising control. We transform naked agents into Shielded Agents.

We deliver trust-as-code through APIs, SDKs, MCPs, and Guardian Agents depending on your need.

OWASP Top 10

The OWASP Top 10 is a standard awareness document for web application security. It represents a broad consensus about the most critical security risks to web applications. Understanding and addressing these risks are crucial for organizations, especially in the pharmaceutical industry, to protect sensitive data and maintain compliance.

1. Injection

Injection flaws occur when untrusted data is sent to an interpreter as part of a command or query. This could lead to malicious actions being performed, such as obtaining unauthorized access to sensitive data.

2. Broken Authentication

When implemented incorrectly, authentication and session management mechanisms can lead to unauthorized individuals gaining access to systems and databases, potentially compromising sensitive information.

3. Sensitive Data Exposure

This risk refers to the exposure of sensitive data, such as personal health information, due to insecure data storage or transmission methods. It can lead to severe compliance violations and the compromise of patient privacy.

4. XML External Entities (XXE)

XXE vulnerabilities can allow attackers to interfere with the processing of XML data, potentially leading to unauthorized access and data leaks.

5. Broken Access Control

Inadequate access control mechanisms can result in unauthorized users gaining privileged access to pharmaceutical systems and data, leading to serious compliance breaches and data compromises.

6. Security Misconfigurations

Misconfigurations, such as leaving default passwords or improper security settings, can create vulnerabilities that malicious actors can exploit to gain access to sensitive pharmaceutical data.

7. Cross-Site Scripting (XSS)

XSS vulnerabilities can allow attackers to inject malicious scripts into web content, potentially leading to the compromise of sensitive information and the disruption of pharmaceutical services.

8. Insecure Deserialization

Insecure deserialization can lead to remote code execution and potentially enable attackers to take control of pharmaceutical systems, compromising sensitive data and patient safety.

9. Using Components with Known Vulnerabilities

Failure to update and patch software components can expose pharmaceutical systems to known vulnerabilities, increasing the risk of data breaches and compliance violations.

10. Insufficient Logging and Monitoring

Inadequate logging and monitoring of pharmaceutical systems can make it difficult to detect and respond to security incidents, potentially allowing malicious activity to go unnoticed.

Schedule Demo

Safeguarding pharmaceutical systems and data from the aforementioned security risks is crucial for maintaining compliance and protecting patient information. Trustwise’s Harmony Ai offers a comprehensive solution to minimize the Trust Gap and ensure AI Trust and Security at scale. Schedule a demo with Trustwise today to learn how our AI Security and Control Layer can empower your organization to address the challenges of AI adoption and compliance in the pharmaceutical industry.